Lopinavir and Ritonavir Oral Solution — FDA Drug Shortage
The FDA lists a drug shortage record for Lopinavir and Ritonavir Oral Solution (oral solution) from AbbVie Inc. with status To Be Discontinued. The shortage was first posted on Jul 24, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- AbbVie Inc.
- Package NDC
- 0074-3956-46
- Dosage Form
- Oral Solution
- Presentation
- Kaletra, Oral Solution, 80 mg/1 mL; 20 mg/1 mL (NDC 0074-3956-46)
- Initial Posting
- Jul 24, 2026